Skip to content

Study · Not a test of the peptide alone · 1989

1 result

[The efficacy of using thymalin in diabetes mellitus in children].

Kurbanov TG, Kal'bieva BM, Zakieva GG

Problemy endokrinologii1 Nov 1989

PMID2695919 (opens in a new tab)PepBankPUB-02695919
Publisher pageAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymalin.

  1. 01HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In children with diabetes mellitus, clinico-metabolic investigations supported efficacy of multimodality therapy containing thymalin.

    In plain wordsIn children with diabetes, clinical and metabolic tests supported efficacy of multimodality treatment containing thymalin.

    Peptide
    Thymalin
    Outcome
    IncreaseClinico-metabolic efficacy
    Study

    n: not reported in source

    Outcome group
    Glycemic control · Metabolic and weight

    Source sentences

    Summary
    Clinico-metabolic investigations proved the efficacy of the use of the new immunomodulator thymalin in multimodality therapy of diabetes mellitus in children.
    1 context sentence
    Summary · context
    A possibility of the use of thymalin was studied in children with diabetes mellitus using adequate immunohormonal investigations.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.